Previous Close | 56.06 |
Open | 55.75 |
Bid | 56.24 x 3000 |
Ask | 56.24 x 1000 |
Day's Range | 55.59 - 56.29 |
52 Week Range | 42.10 - 56.45 |
Volume | |
Avg. Volume | 4,903,043 |
Market Cap | 40.457B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | 18.98 |
EPS (TTM) | 2.96 |
Earnings Date | Jun 13, 2024 - Jun 17, 2024 |
Forward Dividend & Yield | 1.16 (2.06%) |
Ex-Dividend Date | May 14, 2024 |
1y Target Est | 57.68 |
Subscribe to Yahoo Finance Plus to view Fair Value for KR
Kroger said it plans to sell its specialty pharmacy business to an Elevance Health subsidiary. The grocery-store chain said Monday it will sell the business to CarelonRx, a pharmacy benefit manager owned by Elevance. Kroger said the deal was expected to close in the second half of 2024 and wouldn’t affect 2024 guidance.
The financial terms of the deal were not disclosed. The retailer's specialty pharmacy business serves patients with chronic illnesses that require complex care. Kroger Specialty Pharmacy is separate from other Kroger Family of Pharmacies, including in-store retail pharmacies and The Little Clinics, which are not included in the deal.
Grocer Kroger said on Monday it had entered a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a unit of U.S. health insurer Elevance Health. The retailer's specialty pharmacy business serves patients with chronic illnesses that require complex care. Kroger Specialty Pharmacy is separate from other Kroger Family of Pharmacies, including in-store retail pharmacies and The Little Clinics, which are not included in the deal.